Psychedelics Ohio State University gets DEA approval for psilocybin cultivation and research The research will be conducted with stringent regulations and guidelines Rowan DunneMay 19, 2023
News Mind Medicine Australia to supply medical psilocybin and MDMA for clinical trials at no cost It is particularly interested in supporting research that optimizes treatment results and extends the application of psychedelic-assisted therapies Natalia Buendia CalvilloMay 18, 2023
News Lucy Scientific partners with TheraPsil to facilitate patient access to psilocybin The partnership also enables Lucy to introduce natural psilocybin products into the Canadian market Natalia Buendia CalvilloMay 18, 2023
Psychedelics PharmAla Biotech first to get Special Access Program authorization for its MDMA Health Canada granted PharmAla approval to provide its LaNeo product to a physician that will facilitate MDMA-assisted therapy Rowan DunneMay 16, 2023
Psychedelics COMPASS Pathways reports 52% YoY cash loss The company had $126.6M less last quarter than it did in Q1 last year Rowan DunneMay 12, 2023
News LSD microdosing shows promise as treatment for major depression: MindBio study MindBio Therapeutics (CSE:MBIO) says microdoses of LSD could help improve mood and treat mental health conditions such as depression. The Melbourne-based pharmaceutical company announced... Natalia Buendia CalvilloMay 10, 2023
News Optimi Health obtains license to produce natural health products Natural products include probiotics, herbal remedies, vitamins and minerals, homeopathic medicines, traditional medicines among others Natalia Buendia CalvilloMay 10, 2023
News Incannex Healthcare to launch psychedelic clinic in Melbourne The first clinic is set to open in the third quarter of 2023 Natalia Buendia CalvilloMay 5, 2023
Psychedelics EntheoTech Bioscience opens flagship ketamine clinic in Kelowna The company has established a 3,000-square-foot facility to help cater to the growing demand for ketamine therapy Rowan DunneMay 5, 2023
Psychedelics Optimi Health enters $1.2M psilocybin distribution agreement The mushroom cultivator will be supplying a private client for clinical research purposes Rowan DunneMay 4, 2023